Workshop on Cancer Biometrics: Identifying Biomarkers and Surrogates of Tumors in Patients

Masur Auditorium, National Institutes of Health
October 30, 2003

Program Schedule

Thursday, October 30, 2003
7:00am-8:00am Continental Breakfast
8:00am-8:30am Introductory Remarks
Sudhir Srivastava, PhD, MPH
National Cancer Institute
Bethesda, MDRichard Pazdur, MD
Food & Drug Administration
Rockville, MD

Michael Lotze, MD
University of Pittsburgh
Pittsburgh, PA

8:30am-9:00am Immunohistochemistry of Tumors for Immune Cells
George Coukos, MD, PhD
University of Pennsylvania Medical Center
Philadelphia, PA
9:00am-9:30am High Content Cellular Screening
Michael Lotze, MD
University of Pittsburgh School of Medicine
Pittsburgh, PA
9:30am-10:00am Serum and Plasma Proteomics
Emanuel Petricoin, MD
Food and Drug Administration
Bethesda, MD
10:00am-10:15am Refreshment Break
10:15am-10:45am Detection of Circulating Tumor Cells Using Reverse Transcription – PCR
Tony Godfrey, PhD
University of Pittsburgh Cancer Insitute
Pittsburgh, PA
10:45am-11:15am Tumor Capture in the Peripheral Blood
Hans Loibner, PhD
Igeneon AG
Viennna, Austria
11:15am-11:45am Genomic Analysis of Cancer
David Botstein, PhD
Princeton University
Princeton, NJ
11:45am-12:15pm Immunologic Polymorphisms
Grant Gallagher, PhD
University of Medicine and Dentistry of
New Jersey
Newark, NJ
Breakout sessions are by invitation only. Registered Participants will participate in an oral abstract session.
12:15pm-1:00pm Lunch for Registered Participants
1:00pm-2:15pm Oral Abstract Session (Registered Participants)
1:00pm-1:15pm Lunch for Registered Participants
1:00pm-2:15pm High Carbonic Anyhdrase IX Expression Predicts for Renal Cancer Response to IL-2 Therapy
Michael B. Atkins, MD
Beth Israel Deaconess Medical Center
Boston, MA
1:15pm-1:30pm The Application of Surface-Enhanced Laser Desorption/Ionization in Discovery, Identification, and Characterization of Serum Biomarkers in Oncology
Gerald T. Hoehn, PhD
Ciphergen Biosystems, Inc.
Freemont, CA
1:30pm-1:45pm Precision of the ELISpot Assay
Janet L. Lathey, PhD
BBI Biotech
Gaithersburg, MD
1:45pm-2:00pm Multiplexed Direct-Labeled Immunoassays Enable Measurements of a Panel of Prognostic Cancer Biomarkers
Robert Negm, PhD
Schleicher and Schuell BioScience
Keene, NH
2:00pm-2:15pm Preoperative MBL Pathway and Prognosis in Colorectal Cancer
Henriette Ytting, MD
Hvidovre University Hospital
Hvidovre, Denmark
12:15pm-2:15pm Breakout Sessions
(Invited Participants only)
Immunohistochemistry, Tissue Array
Chairs: Guido Sauter, MD
University of Basel
Basel, SwitzerlandPeter Bugelski, PhD
Malvern, PA
Genomic Analysis of Cancer
Chairs: Ena Wang, MD
National Institutes of Health
Bethesda, MDJohn Weinstein, MD, PhD
National Cancer Insitute
Bethesda, MD
Serum and Plasma/Tumor Proteomics, Protein-Protein Interactions
Chairs: Christine Burns, PhD
Pierce Boston Technology Center
Woburn, MAMonica Panelli, PhD
National Institutes of Health
Bethesda, MD
Blood Reverse Transcription-PCR; Tumor Capture in Blood
Chairs: Steven Shivers, PhD
Lakeland Regional Cancer Center
Lakeland, FLMichael Perricone, PhD
Genzyme Corporation
Framingham, MA
High content Cellular Screening of Blood
Chairs: Carmen Scheibenbogen, MD
Universitats Klinikum Benjamin FranklinD. Lansing Taylor, PhD
Cellomics, Inc.
Pittsburgh, PA

Theresa Whiteside, PhD
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Immune Polymorphisms
Chairs: Natin Damle, PhD
Wyeth Research
Pearl River, NYMartin Howell, PhD
Southampton General Hospital
Southampton, United Kingdom
2:15pm-3:00pm Special Lecture: Biologic Therapy of Melanoma
Francesco Marincola, MD
National Institutes of Health
Bethesda, MD
3:00pm-3:30pm Refreshment Break
3:30pm-3:50pm Report on Immunohistochemistry, Tissue Array
Guido Sauter, MD
Peter Bugelski, PhD
3:50pm-4:10pm Report on Genomic Analysis of Cancer
Ena Wang, MD
John Weinstein, MD, PhD
4:10pm-4:30pm Report on Serum and Plasma/Tumor Proteomics, Protein-Protein Interactions
Christine Burns, PhD
Monica Panelli, PhD
4:30pm-4:50pm Report on Reverse Transcription – PCR; Tumor Capture in Blood
Steven Shivers, PhD
Michael Perricone, PhD
4:50pm-5:10pm Report on High content Cellular Screening of Blood
Carmen Scheibenbogen, MD
D. Lansing Taylor, PhD
Theresa Whiteside, PhD
5:10pm-5:30pm Report on Immune Polymorphisms
Natin Damle, PhD
Martin Howell, PhD
5:30pm-6:00pm Concluding Remarks

Registration Fees*
$350 – Industry Representatives
$250 – Non-Members*
$200 – Members*
$200 – Allied Health Professionals
$125 – Students/Fellows-in-Training

*Breakout sessions are by invitation only. Registration allows access to group session activities only.

**Onsite registration will be available.